Jazz Pharmaceuticals
id:
jazz-pharmaceuticals-165-5659933
title:
Jazz Pharmaceuticals
text:
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Ja
brand slug:
wiki
category slug:
encyclopedia
description:
Irish tax-registered pharmaceutical corporation
original url:
https://en.wikipedia.org/wiki/Jazz_Pharmaceuticals
date created:
2013-12-21T00:15:17Z
date modified:
2024-08-29T06:42:05Z
main entity:
{"identifier":"Q16255113","url":"https://www.wikidata.org/entity/Q16255113"}
image:
fields total:
13
integrity:
15